Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting TRAIL agonistic receptors for cancer therapy.
Carlo-Stella C, Lavazza C, Locatelli A, Viganò L, Gianni AM, Gianni L. Carlo-Stella C, et al. Among authors: gianni am, gianni l. Clin Cancer Res. 2007 Apr 15;13(8):2313-7. doi: 10.1158/1078-0432.CCR-06-2774. Clin Cancer Res. 2007. PMID: 17438088 Review.
Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells.
Carlo-Stella C, Lavazza C, Carbone A, Gianni AM. Carlo-Stella C, et al. Among authors: gianni am. Adv Exp Med Biol. 2008;610:100-11. doi: 10.1007/978-0-387-73898-7_8. Adv Exp Med Biol. 2008. PMID: 18593018 Review. No abstract available.
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma.
Di Nicola M, Carlo-Stella C, Mortarini R, Baldassari P, Guidetti A, Gallino GF, Del Vecchio M, Ravagnani F, Magni M, Chaplin P, Cascinelli N, Parmiani G, Gianni AM, Anichini A. Di Nicola M, et al. Among authors: gianni am. Clin Cancer Res. 2004 Aug 15;10(16):5381-90. doi: 10.1158/1078-0432.CCR-04-0602. Clin Cancer Res. 2004. PMID: 15328176 Clinical Trial.
The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice.
Carlo-Stella C, Di Nicola M, Turco MC, Cleris L, Lavazza C, Longoni P, Milanesi M, Magni M, Ammirante M, Leone A, Nagy Z, Gioffrè WR, Formelli F, Gianni AM. Carlo-Stella C, et al. Among authors: gianni am. Cancer Res. 2006 Feb 1;66(3):1799-808. doi: 10.1158/0008-5472.CAN-05-1200. Cancer Res. 2006. PMID: 16452241 Free article.
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.
Lavazza C, Carlo-Stella C, Giacomini A, Cleris L, Righi M, Sia D, Di Nicola M, Magni M, Longoni P, Milanesi M, Francolini M, Gloghini A, Carbone A, Formelli F, Gianni AM. Lavazza C, et al. Among authors: gianni am. Blood. 2010 Mar 18;115(11):2231-40. doi: 10.1182/blood-2009-08-239632. Epub 2010 Jan 14. Blood. 2010. PMID: 20075160 Free article.
323 results